文献
J-GLOBAL ID:202202247118346854
整理番号:22A0215154
腫瘍DNA-メチローム由来エピジェネティックフィンガープリントは術後放射線化学療法後の局所再発のリスクでHPV陰性頭頸部患者を同定する【JST・京大機械翻訳】
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy
著者 (113件):
Tawk Bouchra
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Tawk Bouchra
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Tawk Bouchra
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Tawk Bouchra
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
,
Tawk Bouchra
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
,
Wirkner Ute
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Wirkner Ute
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Wirkner Ute
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Wirkner Ute
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
,
Wirkner Ute
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
,
Schwager Christian
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Schwager Christian
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Schwager Christian
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Schwager Christian
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
,
Schwager Christian
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
,
Rein Katrin
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Rein Katrin
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Rein Katrin
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Rein Katrin
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
,
Rein Katrin
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
,
Zaoui Karim
(Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany)
,
Federspil Philippe A.
(Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany)
,
Adeberg Sebastian
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Adeberg Sebastian
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Adeberg Sebastian
(Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany)
,
Adeberg Sebastian
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany)
,
Linge Annett
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Linge Annett
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
,
Linge Annett
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Linge Annett
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Linge Annett
(National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany)
,
Linge Annett
(Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Linge Annett
(Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany)
,
Ganswindt Ute
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
,
Ganswindt Ute
(Department of Radiation Oncology, Medical University of Innsbruck, Innsbruck, Austria)
,
Hess Julia
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
,
Hess Julia
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Hess Julia
(Clinical Cooperation Group “Personalized Radiotherapy in Head and Neck Cancer”, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Unger Kristian
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
,
Unger Kristian
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Unger Kristian
(Clinical Cooperation Group “Personalized Radiotherapy in Head and Neck Cancer”, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Tinhofer Ingeborg
(German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany)
,
Tinhofer Ingeborg
(Department of Radiooncology and Radiotherapy, Charite University Hospital, Berlin, Germany)
,
Budach Volker
(German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany)
,
Budach Volker
(Department of Radiooncology and Radiotherapy, Charite University Hospital, Berlin, Germany)
,
Lohaus Fabian
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Lohaus Fabian
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
,
Lohaus Fabian
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Lohaus Fabian
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Lohaus Fabian
(National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany)
,
Lohaus Fabian
(Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Lohaus Fabian
(Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany)
,
Krause Mechthild
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Krause Mechthild
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
,
Krause Mechthild
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Krause Mechthild
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Krause Mechthild
(National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany)
,
Krause Mechthild
(Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Krause Mechthild
(Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany)
,
Guberina Maja
(German Cancer Consortium (DKTK), Partner Site Essen, Essen, Germany)
,
Guberina Maja
(Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany)
,
Stuschke Martin
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Stuschke Martin
(Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany)
,
Balermpas Panagiotis
(German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany)
,
Balermpas Panagiotis
(Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland)
,
Rodel Claus
(German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany)
,
Rodel Claus
(Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany)
,
Grosu Anca L.
(German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany)
,
Grosu Anca L.
(Department of Radiation Oncology, Clinical Study Section, University of Freiburg, Freiburg, Germany)
,
Grosu Anca L.
(Department of Radiation Oncology, University of Freiburg, Freiburg, Germany)
,
Schaefer Henning
(German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany)
,
Schaefer Henning
(Department of Radiation Oncology, Clinical Study Section, University of Freiburg, Freiburg, Germany)
,
Zips Daniel
(German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany)
,
Zips Daniel
(Department of Radiation Oncology, Faculty of Medicine and University Hospital Tuebingen, Eberhard Karls Universitaet Tuebingen, Tuebingen, Germany)
,
Combs Stephanie E.
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
,
Combs Stephanie E.
(Department of Radiation Oncology, Technische Universitaet Muenchen, Munich, Germany)
,
Pigorsch Steffi
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
,
Pigorsch Steffi
(Department of Radiation Oncology, Technische Universitaet Muenchen, Munich, Germany)
,
Zitzelsberger Horst
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
,
Zitzelsberger Horst
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Zitzelsberger Horst
(Clinical Cooperation Group “Personalized Radiotherapy in Head and Neck Cancer”, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Baumeister Philipp
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Baumeister Philipp
(Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany)
,
Kirchner Thomas
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
,
Kirchner Thomas
(Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany)
,
Bewerunge-Hudler Melanie
(Genomics and Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany)
,
Weichert Wilko
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
,
Weichert Wilko
(Institute of Pathology, Technische Universitaet Muenchen, Munich, Germany)
,
Hess Jochen
(Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany)
,
Hess Jochen
(Department of Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center, Heidelberg, Germany)
,
Herpel Esther
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Herpel Esther
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Herpel Esther
(Tissue Bank, National Center for Tumor Diseases (NCT), Heidelberg, Germany)
,
Herpel Esther
(Department of Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany)
,
Belka Claus
(German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany)
,
Belka Claus
(Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany)
,
Belka Claus
(Research Unit Radiation Cytogenetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health GmbH, Neuherberg, Germany)
,
Baumann Michael
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Baumann Michael
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Baumann Michael
(German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany)
,
Baumann Michael
(Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Baumann Michael
(OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany)
,
Debus Juergen
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Debus Juergen
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Debus Juergen
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Debus Juergen
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
,
Debus Juergen
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
,
Abdollahi Amir
(German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Abdollahi Amir
(German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany)
,
Abdollahi Amir
(Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Heidelberg, Germany)
,
Abdollahi Amir
(Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany)
,
Abdollahi Amir
(Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University, Heidelberg, Germany)
,
For the DKTK-ROG
資料名:
International Journal of Cancer
(International Journal of Cancer)
巻:
150
号:
4
ページ:
603-616
発行年:
2022年
JST資料番号:
A0267B
ISSN:
0020-7136
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)